Search research articles
Contact Us
Filters
Showing results (201-210 of 303) with videos related to
Page
of 31
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2016
Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms
Keith W Pratz, Brian D Koh, Anand G Patel, et al.
Journal of Hematology & Oncology
|
July 16, 2020
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy
Jorge E Cortes, Florian H Heidel, Walter Fiedler, et al.
Leukemia & Lymphoma
|
June 16, 2020
Clustered incidence of adult acute promyelocytic leukemia in the vicinity of Baltimore
Andrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Leukemia & Lymphoma
|
April 5, 2022
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy
Theodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek, et al.
Leukemia & Lymphoma
|
February 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation
John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2019
A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation
Keith W Pratz, Michelle A Rudek, B Douglas Smith, et al.
Annals of Hematology
|
March 19, 2021
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
Michael Heuser, B Douglas Smith, Walter Fiedler, et al.
The New England Journal of Medicine
|
September 9, 2024
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
David J Jackson, Michael E Wechsler, Daniel J Jackson, et al.
Arthritis Care & Research
|
March 18, 2015
Treatment Algorithms in Systemic Lupus Erythematosus
Chayawee Muangchan, Ronald F van Vollenhoven, Sasha R Bernatsky, et al.
Annals of Hematology
|
May 12, 2021
Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
Michael Heuser, B Douglas Smith, Walter Fiedler, et al.
Page
of 31
Search research articles
Search
Showing results (201-210 of 303) with videos related to
Sort By:
Page
of 31
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2016
Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms
Keith W Pratz, Brian D Koh, Anand G Patel, et al.
Journal of Hematology & Oncology
|
July 16, 2020
Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy
Jorge E Cortes, Florian H Heidel, Walter Fiedler, et al.
Leukemia & Lymphoma
|
June 16, 2020
Clustered incidence of adult acute promyelocytic leukemia in the vicinity of Baltimore
Andrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Leukemia & Lymphoma
|
April 5, 2022
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy
Theodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek, et al.
Leukemia & Lymphoma
|
February 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation
John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2019
A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation
Keith W Pratz, Michelle A Rudek, B Douglas Smith, et al.
Annals of Hematology
|
March 19, 2021
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
Michael Heuser, B Douglas Smith, Walter Fiedler, et al.
The New England Journal of Medicine
|
September 9, 2024
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
David J Jackson, Michael E Wechsler, Daniel J Jackson, et al.
Arthritis Care & Research
|
March 18, 2015
Treatment Algorithms in Systemic Lupus Erythematosus
Chayawee Muangchan, Ronald F van Vollenhoven, Sasha R Bernatsky, et al.
Annals of Hematology
|
May 12, 2021
Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
Michael Heuser, B Douglas Smith, Walter Fiedler, et al.
Page
of 31